Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: Implications for LPS-induced nuclear factor-κB binding activity

European Journal of Biochemistry

Volumn 268, Issue 16, 2001, Pages 4489-4496

  Hourton, Delphine ^a   Stengel, Dominique ^a   John Chapman, M ^b   Ninio, Ewa ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Inflammation; Lipid peroxidation; Lysophos phatidylcholine; Macrophage; Platelet activating factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MALONALDEHYDE; MESSENGER RNA; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MACROPHAGE; MONOCYTE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0034832172     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2001.02372.x     Document Type: Article

References (49)

1. Mechanisms of disease-atherosclerosis - An inflammatory disease
2. Platelet-activating factor: The biosynthetic and catabolic enzymes
3. Phagocytic activation induces formation of PAF-acether in human monocyte-derived macrophages and in macrophage-foam cells: Relevance to the inflammatory reaction in atherogenesis
4. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF: Acetylhydrolase in dense LDL
5. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease
6. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung
7. Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and in-dependent pathways
8. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells - Role of multiple G proteins and receptor phosphorylation
9. Platelet-activating factor: Receptors and signal transduction
10. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells
11. The human leukocyte platelet-activating factor receptor
12. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes
13. Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP
14. Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor
15. Structure and regulation of platelet-activating-factor receptor gene
16. Expression of the PAF receptor in human monocyte-derived macrophages is down-regulated by oxidized low-density lipoprotein: Relevance to the inflammatory phase of atherogenesis
17. Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques. Relevance to progression of atherosclerosis
18. Mechanical stretch induces platelet-activating-factor receptor gene expression through the NF-kappa B transcription factor
19. Functional characterization of the promoter region of the platelet-activating factor receptor gene
20. Structure, regulation and function of NF-kappaB
21. Role of nuclear factor-kappaB in atherogenesis
22. Function and activation of NF-kappa B in the immune system
23. Structural identification by mass spectrometry of oxidized phospholipids in minimally modified low density lipoproteins that induce monocyte/endothelial interactions and evidence for their presence in vivo
24. Oxidised low density lipoprotein inhibits lipopoly-saccharide-induced binding of nuclear factor-KappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1β in macrophages
25. The effects of oxidised low density lipoproteins on inducible mouse macrophage gene expression and stimulus dependent
26. Low density lipoprotein is saturable by pro-oxidant copper
27. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: Its use for evaluation of antioxidants
28. Kinetic analysis of copper-induced peroxidation of LDL
29. 2+ mobilisation and eicosanoid release in human Mono Mac 6 cells
30. Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages
31. Oxidized low density lipoprotein suppresses activation of NFκB in macrophages via a pertussis toxin-sensitive signaling mechanism
32. Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state - A key role for lysophosphatidylcholine
33. A CD14-independent LPS cluster
34. LPS induction of geneexpression in human monocytes
35. Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IκB kinase signalsome activation and IκB proteolysis
36. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor
37. IFN-γ up-regulates platelet-activating factor receptor gene expression in human monocytes
38. Augmented expression of platelet-activating factor receptor gene by TNF-alpha through transcriptional activation in human monocytes
39. Platelet-activating Factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kB
40. Oxidized low-density lipoprotein and peroxisome-proliferato-activated receptor α downregulate platelet-activating-factor receptor expression in human macrophages
41. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
42. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-κB in human vascular smooth muscle cells
43. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
44. Potential involvement of type II phospholipase A2 in atherosclerosis
45. Tissue factor expression of human monocytes is suppressed by lysophosphotidylcholine
46. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells
47. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription
48. 4-Hydroxynonenal prevents NF-kB activation and tumor necrosis factor expression by inhibiting IkB phosphorylation and subsequent proteolysis
49. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells